Frankenfield Christopher James

Xilio Therapeutics, Inc. · Chief Financial Officer

Frankenfield Christopher James is listed in public filings as officer: Chief Financial Officer. This Frankenfield Christopher James insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Xilio Therapeutics, Inc. (XLO). Investors use Frankenfield Christopher James's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Xilio Therapeutics, Inc.XLO	$16k24.8k shares	SellJan 2, 2026	$4.5K7k shares	$0.6432	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Xilio Therapeutics, Inc.XLO	--31.8k shares	Grant / ExerciseJan 1, 2026	Disclosure amount unavailable19.4k shares	--	--
Xilio Therapeutics, Inc.XLO	$562k668.8k shares	Grant / ExerciseDec 31, 2025	$562.5K668.8k shares	$0.841	--
Xilio Therapeutics, Inc.XLO	$0300k shares	OtherNov 21, 2025	$835.5K300k shares	$2.79	--
Xilio Therapeutics, Inc.XLO	$778k925k shares	Grant / ExerciseNov 21, 2025	$777.9K925k shares	$0.841	--
Xilio Therapeutics, Inc.XLO	$037.3k shares	OtherNov 21, 2025	$596.7K37.3k shares	$16.00	--
Xilio Therapeutics, Inc.XLO	$045k shares	OtherNov 21, 2025	$569.7K45k shares	$12.66	--
Xilio Therapeutics, Inc.XLO	$450k300k shares	Grant / ExerciseNov 21, 2025	$450.0K300k shares	$1.50	--
Xilio Therapeutics, Inc.XLO	$0150k shares	OtherNov 21, 2025	$412.5K150k shares	$2.75	--
Xilio Therapeutics, Inc.XLO	$0117k shares	OtherNov 21, 2025	$314.7K117k shares	$2.69	--
Xilio Therapeutics, Inc.XLO	$233k155.1k shares	Grant / ExerciseNov 21, 2025	$232.6K155.1k shares	$1.50	--
Xilio Therapeutics, Inc.XLO	$225k150k shares	Grant / ExerciseNov 21, 2025	$225.0K150k shares	$1.50	--
Xilio Therapeutics, Inc.XLO	$176k117k shares	Grant / ExerciseNov 21, 2025	$175.5K117k shares	$1.50	--
Xilio Therapeutics, Inc.XLO	$023.8k shares	OtherNov 21, 2025	$158.2K23.8k shares	$6.65	--
Xilio Therapeutics, Inc.XLO	$68k45k shares	Grant / ExerciseNov 21, 2025	$67.5K45k shares	$1.50	--
Xilio Therapeutics, Inc.XLO	$56k37.3k shares	Grant / ExerciseNov 21, 2025	$55.9K37.3k shares	$1.50	--
Xilio Therapeutics, Inc.XLO	$020k shares	OtherNov 21, 2025	$42.6K20k shares	$2.13	--
Xilio Therapeutics, Inc.XLO	$36k23.8k shares	Grant / ExerciseNov 21, 2025	$35.7K23.8k shares	$1.50	--
Xilio Therapeutics, Inc.XLO	$30k20k shares	Grant / ExerciseNov 21, 2025	$30.0K20k shares	$1.50	--
Xilio Therapeutics, Inc.XLO	$53k75k shares	Grant / ExerciseApr 15, 2025	$53.4K75k shares	$0.712	--
Xilio Therapeutics, Inc.XLO	$12k12.4k shares	SellJan 2, 2025	$6.8K7k shares	$0.9837	--
Xilio Therapeutics, Inc.XLO	$240k251k shares	Grant / ExerciseJan 1, 2025	$239.7K251k shares	$0.955	--
Xilio Therapeutics, Inc.XLO	--19.4k shares	Grant / ExerciseJan 1, 2025	Disclosure amount unavailable19.4k shares	--	--
Xilio Therapeutics, Inc.XLO	$47k52k shares	Grant / ExerciseAug 3, 2024	$46.5K52k shares	$0.895	--